Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
BAER-101 demonstrated full suppression of seizure activity in SynapCell s GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure.
MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.